Derrick Teal  I  Editor-in-Chief

According to the CDC, more than 38 million Americans have diabetes, and about 90% to 95% of them have type 2 diabetes. Being overweight is one of the known risk factors for type 2 diabetes, as is being inactive and being 45 or older. As many of us know, it becomes more difficult to lose weight as we get older. And if you already have type 2 diabetes, losing weight can be even more difficult.

During last month’s webinar about FOOD ENGINEERING’s Top 100 Food and Beverage Companies, I was joined by Refrigerated & Frozen Foods Editor-in-Chief Kelley Rodriguez to talk about trends that are having an impact or will be having an impact on food and beverage manufacturers. In her view, that will be users of GLP-1.

GLP-1 (glucagon-like peptide 1) is a class of type 2 diabetes drugs that improves blood sugar control and may also help with weight loss. With about 1 in 10 Americans having diabetes, most of them with type 2, it stands to reason that GLP-1 drugs are going to become popular with many trying to lose weight.

To that end, Nestlé launched in September a new brand of frozen meals designed to provide dietary support to GLP-1 users and consumers focused on weight management. Called Vital Pursuit, the line offers 14 varieties that include at least 20g of protein and contain essential nutrients such as vitamin A, vitamin C, potassium, calcium or iron. The meals are made with quality proteins, vegetables and whole grains.

"People taking these medications not only have a decreased appetite, but they must adjust their diets with a sharper focus on smaller portions, while also prioritizing beneficial nutrients for their health," says Marlene Schmidt, registered dietitian and senior health & wellness manager at Nestlé. "To complement these eating habits, we're striving to take the guesswork out of mealtime with thoughtfully portioned, nutritious, accessible options."

The company plans to release a ready-to-drink beverage with 30g of protein and no added sugar in 2025. FE